Cannabis legalization and Parkinson's disease. Advantages and disadvantages

The discussion about the use of medical cannabis to treat various diseases has increased worldwide in recent years. The potential of cannabis-based therapies is being intensively researched, particularly for Parkinson's disease, a neurodegenerative disease that affects millions of people.

The study of dopamine, serotonin and social behavior

The neurotransmitters dopamine and serotonin in the brain have a significant influence on our social behavior, as new research shows. For the first time, their interaction has been directly observed thanks to the participation of four Parkinson's patients in an experiment during brain surgery. The results reveal a neurochemical mechanism that explains our tendency to make decisions in a social context. Additionally, in the long term, this technique could help to better understand changes in brain chemistry associated with Parkinson's disease.

AI in healthcare: the 10.000 Brains Project

Hypotheses investigated include inflammation, changes in intestinal flora and hygiene factors. Early intervention such as a Mediterranean diet change could reduce the risk of these diseases. Further research is required to clarify the exact connections.

The gut-brain connection: A look at Alzheimer's and Parkinson's

Hypotheses investigated include inflammation, changes in intestinal flora and hygiene factors. Early intervention such as a Mediterranean diet change could reduce the risk of these diseases. Further research is required to clarify the exact connections.

Musk or Messiah? The ethical challenges of Neuralink

Musk or Messiah? The ethical challenges of Neuralink

Elon Musk, the man behind Tesla and SpaceX, has a vision with Neuralink: curing diseases, improving human abilities and ultimately merging humans and machines. But behind the tantalizing promises of healing and progress lurk serious ethical concerns.

Nanoparticles and Parkinson's disease

Plastic waste, especially nanoparticles made from the plastic polystyrene, could influence the development of Parkinson's disease, according to a new study. Researchers found that these tiny plastic particles form a chemical bond with alpha-synuclein, a protein whose deposits in the brain mark the onset of Parkinson's disease.

Quo vadis dPV?

Quo Vadis dPV?

My very personal story
 In 2019 I was surprised by the diagnosis of Parkinson's and anyone who has had this experience knows the feeling of helplessness, panic and uncertainty.

What you need to know about Parkinson's

When a person with Parkinson's or a relative wants to find out about a possible disease, accompanying symptoms play a crucial role. These can affect different parts of the body, including skin, skeleton, sensory organs and psyche. The severity and occurrence of these symptoms vary from person to person, and it is important to note that some symptoms may have other causes.

Produodopa. The new medication standard?

However, the  perspectives changed fundamentally with the introduction of Produodopa®, a subcutaneous infusion solution. Continuous infusion over 24 hours using a portable pump ensures more constant effective levels. The crucial advantage for all of us is that no surgery is required to insert the subcutaneous cannula. This less invasive treatment option is a huge relief for all of us.

MRgFUS

Karl Walter, an 80-year-old resident of Karlsfeld, has had an impressive and transformative experience with Parkinson's disease. This condition, characterized by a constant shaking, also known as tremor, had severely affected his ability to carry out everyday tasks. Even basic tasks, such as tying a tie or lacing his shoes, posed major challenges for him.